ReviewInternational journal of molecular sciences2021

The NFκB Antagonist CDGSH Iron-Sulfur Domain 2 Is a Promising Target for the Treatment of Neurodegenerative Diseases.

Woon-Man Kung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.